Real-time enrollment status for this fibrosing interstitial lung disease clinical trial
Current Status
Recruiting
Checked: July 25, 2026 at 11:50 AM UTC
| NCT Number | NCT07366034 |
| Recruiting Status | Recruiting |
| Condition | Fibrosing Interstitial Lung Disease |
| Phase | PHASE3 |
| Target Enrollment | 35 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | July 24, 2026 (Yesterday) |
As of July 25, 2026: Clinical trial NCT07366034 is currently recruiting participants. This phase3 study for fibrosing interstitial lung disease is actively seeking new participants at 7 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07366034 is actively recruiting participants as of July 25, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07366034 was last updated Yesterday (July 24, 2026). HelloStudys verifies this status automatically.